NovAccess Global Inc
NovAccess Global Inc., a biopharmaceutical company, engages in the development of novel immunotherapies to treat brain tumor patients in the United States. It specializes in cutting-edge research related to utilizing a patient's immune system to attack the cancer. NovAccess Global Inc. was incorporated in 1997 and is headquartered in New York, New York.
NovAccess Global Inc (XSNX) - Total Assets
Latest total assets as of September 2024: $273.56K USD
Based on the latest financial reports, NovAccess Global Inc (XSNX) holds total assets worth $273.56K USD as of September 2024.
Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments.
NovAccess Global Inc - Total Assets Trend (2003–2024)
This chart illustrates how NovAccess Global Inc’s total assets have evolved over time, based on quarterly financial data. Explore and compare other companies by total assets.
NovAccess Global Inc - Asset Composition Analysis
Current Asset Composition (September 2024)
NovAccess Global Inc's total assets of $273.56K consist of 100.0% current assets and 0.0% non-current assets.
| Asset Category | Amount (USD) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | $0.00 | 34.4% |
| Accounts Receivable | $0.00 | 0.0% |
| Inventory | $0.00 | 0.0% |
| Property, Plant & Equipment | $0.00 | 0.0% |
| Intangible Assets | $0.00 | 0.0% |
| Goodwill | $0.00 | 0.0% |
Asset Composition Trend (2003–2024)
This chart illustrates how NovAccess Global Inc's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution.
Key Asset Composition Facts
- Current vs. Non-Current Assets: NovAccess Global Inc's current assets represent 100.0% of total assets in 2024, an increase from 99.9% in 2003.
- Cash Position: Cash and equivalents constituted 34.4% of total assets in 2024, down from 99.9% in 2003.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 0.0% of total assets, unchanged from 0.0% in 2003.
- Asset Diversification: The largest asset category is goodwill at 0.0% of total assets.
NovAccess Global Inc Competitors by Total Assets
Key competitors of NovAccess Global Inc based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
MedPacto Inc
KQ:235980
|
Korea | ₩51.58 Billion |
|
2H0
F:2H0
|
Germany | €15.27 Million |
|
Shenzhen CAU Technology Co Ltd
SHE:000004
|
China | CN¥260.55 Million |
|
Pacific Shuanglin Bio pharmacy Co Ltd
SHE:000403
|
China | CN¥9.58 Billion |
|
Nanhua Bio Medicine Co Ltd
SHE:000504
|
China | CN¥841.96 Million |
|
Jiangsu Sihuan Bioengineering Co Ltd
SHE:000518
|
China | CN¥509.14 Million |
|
Chengzhi Shareholding Co Ltd
SHE:000990
|
China | CN¥27.52 Billion |
|
Hualan Biological EngineeringInc
SHE:002007
|
China | CN¥16.27 Billion |
NovAccess Global Inc - Asset Efficiency Metrics
Asset efficiency metrics measure how effectively a company uses its assets to generate revenue and profits. These indicators help investors evaluate management's ability to deploy capital efficiently.
Asset Turnover Ratio
Measures how efficiently a company uses its assets to generate sales
Lower asset utilization - NovAccess Global Inc generates 0.00x its asset value in annual revenue.
Return on Assets (ROA)
Measures how efficiently a company uses its assets to generate profits
Negative ROA - NovAccess Global Inc is currently not profitable relative to its asset base.
NovAccess Global Inc - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 0.01 | 0.01 | 0.18 |
| Quick Ratio | 0.01 | 0.01 | 0.18 |
| Cash Ratio | 0.00 | 0.00 | 0.00 |
| Working Capital | $-7.65 Million | $ -7.80 Million | $ -2.17 Million |
NovAccess Global Inc - Advanced Valuation Insights
This section examines the relationship between NovAccess Global Inc's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | - |
| Latest Market Cap to Assets Ratio | 0.20 |
| Asset Growth Rate (YoY) | 0.0% |
| Total Assets | $62.25K |
| Market Capitalization | $12.38K USD |
Valuation Analysis
Below Book Valuation: The market values NovAccess Global Inc's assets below their book value (0.20 x), which may indicate investor concerns about asset quality or future growth.
Slight Asset Contraction: NovAccess Global Inc's assets decreased by 0.0% over the past year, which may reflect streamlining or optimization of resources.
Annual Total Assets for NovAccess Global Inc (2003–2024)
The table below shows the annual total assets of NovAccess Global Inc from 2003 to 2024.
| Year | Total Assets | Change |
|---|---|---|
| 2024-09-30 | $62.25K | 0.00% |
| 2023-09-30 | $62.25K | -50.16% |
| 2022-09-30 | $124.90K | -39.99% |
| 2021-09-30 | $208.13K | +116829.21% |
| 2020-09-30 | $178.00 | -99.92% |
| 2019-09-30 | $215.19K | +39.57% |
| 2018-09-30 | $154.18K | +219.25% |
| 2017-09-30 | $48.29K | -26.72% |
| 2016-09-30 | $65.90K | -30.53% |
| 2015-09-30 | $94.87K | +36.60% |
| 2014-09-30 | $69.45K | -54.16% |
| 2013-09-30 | $151.51K | -74.78% |
| 2012-09-30 | $600.75K | +194.45% |
| 2011-09-30 | $204.02K | -61.19% |
| 2010-09-30 | $525.67K | -61.79% |
| 2009-09-30 | $1.38 Million | -76.04% |
| 2008-09-30 | $5.74 Million | 0.00% |
| 2007-09-30 | $5.74 Million | -16.59% |
| 2006-09-30 | $6.88 Million | +1458.69% |
| 2005-09-30 | $441.68K | +512.48% |
| 2004-09-30 | $72.11K | +2969.99% |
| 2003-09-30 | $2.35K | -- |